Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Shanghai Hezhou Pharmaceutical

Request full access

Discovery and development of innovative oncology drugs

ChinaFounded 2022Biotech & Life Sciences

About Shanghai Hezhou Pharmaceutical

Shanghai Hezhou Pharmaceutical, also known as Haihe Pharmaceutical, is a biotechnology company focused on the discovery and development of innovative drugs for oncology. The company is advancing a pipeline of drug candidates, with a significant number having reached the clinical trial stage and several receiving Investigational New Drug (IND) approval in the United States. The business model centers on the research, development, and eventual commercialization of these novel cancer therapies on a global scale.

Dr. Ruiping Dong serves as the CEO of the company. Haihe Pharmaceutical has successfully secured significant funding to advance its research and development efforts. In July 2020, the company announced the closing of a ¥1.20 billion Series B financing round. This funding was led by Warburg Pincus and included participation from CMBI, Legend Capital, and CICC Capital, among others. Previous Series A investors such as BioTrack Capital and Atlas Capital also participated in the round, demonstrating continued confidence in the company's pipeline and strategy. The proceeds are intended to accelerate the clinical development and commercialization of its portfolio of oncology drugs.

Source: Dealroom company data

At a glance

Status
Operational
Employees
7
Open positions
None listed
Dealroom signal
40.2/100
Industry
Health
Sub-industry
BioTechnology
Sector
Oncology, Drug Development, DT and LS, science-based
Business model
Manufacturing
Client focus
B2B

Funding history

2 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES A✓Equity / VC Aug 2025 $20M $80M Undisclosed ↗
SEED✓Equity / VC Oct 2023 $2.8M $11M Eight Roads Ventures ↗
Showing the latest 2 of 2 recorded eventsBook a demo for the full funding history →

Growth signals

Shanghai Hezhou Pharmaceutical website traffic

Latest recorded traffic for Shanghai Hezhou Pharmaceutical is 1.3K monthly website visits, up 32.7% over the last three months. Shanghai Hezhou Pharmaceutical's team grew 0% over the past year.

Latest monthly visits1.3K 3-month web change+32.7% 1-year team growth0%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Shanghai Hezhou Pharmaceutical in its local ecosystem

Live from Dealroom

The Shanghai Hezhou Pharmaceutical office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

2 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed1 investor entered at this stage

Other known investors1 additional known investor

Employees 7 total headcount
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
1 countries with
team presence
🇨🇳 China100%
1 country shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Shanghai Hezhou Pharmaceutical on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Shanghai Hezhou Pharmaceutical’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.